Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: Algernon Pharmaceuticals

Industry, Pharma

Algernon Pharmaceuticals Announces Acceleration of Expiry Date of Warrants

December 24, 2020

Via: BioSpace

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company announces that the Company has elected to exercise its acceleration right under the warrant indenture (the “Indenture”) governing the common share […]